Company
Audentes Therapeutics, Inc. (0001628738)
Standardized SEC financial data for Audentes Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001628738 · Biological Products, (No Diagnostic Substances).
Return on equity
-20.4%
Free cash flow
-$119.6M
Current ratio
17.60×
Income statement
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| R&D expense | $48.8M | $75.9M | $104.4M |
| SG&A expense | $11.3M | $17.3M | $30.0M |
| Operating income | — | -$93.2M | — |
Standardized from Audentes Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Cash & equivalents | $36.4M | $39.0M | $144.3M |
| Total current assets | $108.4M | $137.0M | $419.8M |
| Property, plant & equipment | $18.9M |
Cash flow
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Operating cash flow | -$49.0M | -$84.6M | -$108.0M |
| Capital expenditures | $16.7M | $7.6M | $11.6M |
| Free cash flow | -$65.7M | -$92.1M |
Get 0001628738 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001628738/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001628738/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"